Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Background: Amyotrophic lateral sclerosis is a neurodegenerative disease of motor neurons resulting in progressive paralysis and death, typically within 3–5 years. Although the heritability of ALS is about 60%, only about 11% is explained by common gene variants, suggesting that other forms of genetic variation are important. Telomeres maintain DNA integrity during cellular replication and shorten naturally with age. Gender and age are risk factors for ALS and also associated with telomere length. We therefore investigated telomere length in ALS. Methods: We estimated telomere length by applying a bioinformatics analysis to whole genome sequence data of leukocyte-derived DNA from people with ALS and age and gender-matched matched controls in a UK population. We tested the association of telomere length with ALS and ALS survival. Results: There were 1241 people with ALS and 335 controls. The median age for ALS was 62.5 years and for controls, 60.1 years, with a male–female ratio of 62:38. Accounting for age and sex, there was a 9% increase of telomere length in ALS compared to matched controls. Those with longer telomeres had a 16% increase in median survival. Of nine SNPs associated with telomere length, two were also associated with ALS: rs8105767 near the ZNF208 gene (p1⁄41.29 10 ) and rs6772228 (p = 0.001), which is in an intron for the PXK gene. Conclusions: Longer telomeres in leukocyte-derived DNA are associated with ALS, and with increased survival in those with ALS.

[1]  M. Sporn,et al.  Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. , 2011, Free radical biology & medicine.

[2]  Steven L Salzberg,et al.  HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.

[3]  Jana Marie Schwarz,et al.  MutationTaster evaluates disease-causing potential of sequence alterations , 2010, Nature Methods.

[4]  Olubunmi Abel,et al.  ALSoD: A user‐friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics , 2012, Human mutation.

[5]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[6]  Patrizia Rizzu,et al.  Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.

[7]  H. Okazawa,et al.  Increased oxidative stress is related to disease severity in the ALS motor cortex , 2015, Neurology.

[8]  H. Li,et al.  Curcumin abolishes mutant TDP-43 induced excitability in a motoneuron-like cellular model of ALS , 2014, Neuroscience.

[9]  Honghao Zhou,et al.  Plant Polyphenol Curcumin Significantly Affects CYPIA2 and CYP2A6 Activity in Healthy, Male Chinese Volunteers , 2010, The Annals of pharmacotherapy.

[10]  John Q. Trojanowski,et al.  Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS , 2010, Nature.

[11]  H. Juan,et al.  Unexpected effect of concomitantly administered curcumin on the pharmacokinetics of talinolol in healthy Chinese volunteers , 2007, European Journal of Clinical Pharmacology.

[12]  Shang Li,et al.  The role of telomere biology in cancer. , 2013, Annual review of pathology.

[13]  Geoff Der,et al.  Gender and telomere length: Systematic review and meta-analysis , 2014, Experimental Gerontology.

[14]  Vincent J. Henry,et al.  OMICtools: an informative directory for multi-omic data analysis , 2014, Database J. Biol. Databases Curation.

[15]  Karsten M. Borgwardt,et al.  The Evaluation of Tools Used to Predict the Impact of Missense Variants Is Hindered by Two Types of Circularity , 2015, Human mutation.

[16]  D. Breljak,et al.  Molecular basis of amyotrophic lateral sclerosis , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[17]  John W Griffin,et al.  DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). , 2004, American journal of human genetics.

[18]  R. D'Alessandro,et al.  Telomerase expression in amyotrophic lateral sclerosis (ALS) patients , 2014, Journal of Human Genetics.

[19]  M. Naidu,et al.  Effect of NCB-02, Atorvastatin and Placebo on Endothelial Function, Oxidative Stress and Inflammatory Markers in Patients with Type 2 Diabetes Mellitus , 2008, Drugs in R&D.

[20]  Colin Campbell,et al.  An integrative approach to predicting the functional effects of non-coding and coding sequence variation , 2015, Bioinform..

[21]  C. Shaw,et al.  Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase , 2010, Proceedings of the National Academy of Sciences.

[22]  Albert C. Ludolph,et al.  Guidelines for preclinical animal research in ALS/MND: A consensus meeting , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[23]  Sufen Yang,et al.  Curcumin Protects Dopaminergic Neuron Against LPS Induced Neurotoxicity in Primary Rat Neuron/Glia Culture , 2008, Neurochemical Research.

[24]  Iuliana Ionita-Laza,et al.  Sequence kernel association tests for the combined effect of rare and common variants. , 2013, American journal of human genetics.

[25]  Yansu Guo,et al.  Activation of nuclear factor erythroid 2-related factor 2 cytoprotective signaling by curcumin protect primary spinal cord astrocytes against oxidative toxicity. , 2011, Biological & pharmaceutical bulletin.

[26]  J. Hesselink Reversible motor neuron disease. , 1992, Neurology.

[27]  S. Inoue,et al.  A Novel Acylaminoimidazole Derivative, WN1316, Alleviates Disease Progression via Suppression of Glial Inflammation in ALS Mouse Model , 2014, PloS one.

[28]  M. Moss,et al.  Protandim does not influence alveolar epithelial permeability or intrapulmonary oxidative stress in human subjects with alcohol use disorders. , 2012, American journal of physiology. Lung cellular and molecular physiology.

[29]  M. Majeed,et al.  Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. , 1998, Planta medica.

[30]  I. Gülçin,et al.  Antioxidant and radical scavenging properties of curcumin. , 2008, Chemico-biological interactions.

[31]  I. Katona,et al.  Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice. , 2012, Brain : a journal of neurology.

[32]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[33]  A. Goris,et al.  EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans , 2012, Nature Medicine.

[34]  Patrizia Sola,et al.  Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS , 2011, Neuron.

[35]  Wael K Al-Delaimy,et al.  Curcumin Content of Turmeric and Curry Powders , 2006, Nutrition and cancer.

[36]  Warren W. Kretzschmar,et al.  Molecular Signatures of Major Depression , 2015, Current Biology.

[37]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[38]  A. Higginbottom,et al.  S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis☆ , 2013, Free radical biology & medicine.

[39]  A. Al-Chalabi,et al.  An estimate of amyotrophic lateral sclerosis heritability using twin data , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[40]  S. W. Pedersen,et al.  Immune system alterations in amyotrophic lateral sclerosis , 2013, Acta neurologica Scandinavica.

[41]  S. Yim,et al.  Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor kappab bindings in BV2 microglial cells. , 2004, Journal of pharmacological sciences.

[42]  D. Eastmond,et al.  Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells. , 1995, Mutation research.

[43]  S. C. Chafe,et al.  Mutations in the Profilin 1 Gene Cause Familial Amyotrophic Lateral Sclerosis , 2012, Nature.

[44]  P. Lansdorp,et al.  Telomere length measurements using fluorescence in situ hybridization and flow cytometry. , 2004, Methods in cell biology.

[45]  E. Blackburn,et al.  Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging , 2006, Nature Medicine.

[46]  Gabor T. Marth,et al.  Haplotype-based variant detection from short-read sequencing , 2012, 1207.3907.

[47]  R. Reddel,et al.  Alternative lengthening of telomeres: models, mechanisms and implications , 2010, Nature Reviews Genetics.

[48]  J. Trojanowski,et al.  A yeast functional screen predicts new candidate ALS disease genes , 2011, Proceedings of the National Academy of Sciences.

[49]  K. K. Sakariah,et al.  Improved HPLC method for the determination of curcumin, demethoxycurcumin, and bisdemethoxycurcumin. , 2002, Journal of agricultural and food chemistry.

[50]  J. Chang-Claude,et al.  A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk , 2013, Human molecular genetics.

[51]  Yongwook Choi,et al.  PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels , 2015, Bioinform..

[52]  R. Kaji,et al.  Nuclear factor κ B expression in patients with sporadic amyotrophic lateral sclerosis and hereditary amyotrophic lateral sclerosis with optineurin mutations. , 2012, Clinical neuropathology.

[53]  J. Barrett,et al.  Telomere length and common disease: study design and analytical challenges , 2015, Human Genetics.

[54]  Hongyu Zhou,et al.  The targets of curcumin. , 2011, Current drug targets.

[55]  A. Ludolph,et al.  Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS , 2004, Neurology.

[56]  M. Miyashita,et al.  Effects of Curcumin Supplementation on Exercise-Induced Oxidative Stress in Humans , 2013, International Journal of Sports Medicine.

[57]  T. Ma,et al.  Applications and limitations of polymerase chain reaction amplification. , 1995, Chest.

[58]  Justin C. Fay,et al.  Identification of deleterious mutations within three human genomes. , 2009, Genome research.

[59]  Ammar Al-Chalabi,et al.  Clinical genetics of amyotrophic lateral sclerosis: what do we really know? , 2011, Nature Reviews Neurology.

[60]  James D. Herbsleb,et al.  Social coding in GitHub: transparency and collaboration in an open software repository , 2012, CSCW.

[61]  T. Spector,et al.  Human telomere biology: pitfalls of moving from the laboratory to epidemiology. , 2006, International journal of epidemiology.

[62]  Bruce L. Miller,et al.  Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.

[63]  K. Abel,et al.  Curcumins Promote Monocytic Gene Expression Related to β-Amyloid and Superoxide Dismutase Clearance , 2011, Neurodegenerative Diseases.

[64]  Andrew D. Johnson,et al.  Genome-wide association identifies OBFC1 as a locus involved in human leukocyte telomere biology , 2010, Proceedings of the National Academy of Sciences.

[65]  P. Lansdorp,et al.  Telomere length measurement by fluorescence in situ hybridization and flow cytometry: tips and pitfalls. , 2002, Cytometry.

[66]  G. Grunwald,et al.  The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy. , 2006, Free radical biology & medicine.

[67]  T. Chiba,et al.  Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers , 2011, Cancer Chemotherapy and Pharmacology.

[68]  Kunxi Zhang,et al.  Neuroprotective effects of diallyl trisulfide in SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis , 2011, Brain Research.

[69]  新田 隆,et al.  心房細動手術(手術のtips and pitfalls) , 2007 .

[70]  Xueying Wang,et al.  Telomere shortening in human diseases , 2013, The FEBS journal.

[71]  G. Atzmon,et al.  Telomere Length and Aging , 2012 .

[72]  Yansu Guo,et al.  The modest impact of transcription factor Nrf2 on the course of disease in an ALS animal model , 2013, Laboratory Investigation.

[73]  Johnny S. H. Kwan,et al.  Predicting Mendelian Disease-Causing Non-Synonymous Single Nucleotide Variants in Exome Sequencing Studies , 2013, PLoS genetics.

[74]  Y. Panahi,et al.  Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis. , 2015, Clinical nutrition.

[75]  Mauno Vihinen,et al.  VariBench: A Benchmark Database for Variations , 2013, Human mutation.

[76]  M. Nalls,et al.  Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans , 2012, Human molecular genetics.

[77]  Lorne Zinman,et al.  Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis , 2014, Nature Neuroscience.

[78]  K. Chopra,et al.  Protective effect of curcumin against chronic alcohol-induced cognitive deficits and neuroinflammation in the adult rat brain , 2013, Neuroscience.

[79]  A. Sahebkar,et al.  Curcuminoids Modulate Pro‐Oxidant–Antioxidant Balance but not the Immune Response to Heat Shock Protein 27 and Oxidized LDL in Obese Individuals , 2013, Phytotherapy research : PTR.

[80]  Brittany N. Lasseigne,et al.  Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways , 2015, Science.

[81]  Yung-Hyun Choi,et al.  Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia , 2007, Acta Pharmacologica Sinica.

[82]  Michael Benatar,et al.  Prion-like domain mutations in hnRNPs cause multisystem proteinopathy and ALS , 2013, Nature.

[83]  S. Petri,et al.  Nuclear Erythroid 2-Related Factor 2-Antioxidative Response Element Signaling Pathway in Motor Cortex and Spinal Cord in Amyotrophic Lateral Sclerosis , 2008, Journal of neuropathology and experimental neurology.

[84]  M. Diederich,et al.  Effect of Curcumin on Nuclear Factor κB Signaling Pathways in Human Chronic Myelogenous K562 Leukemia Cells , 2009 .

[85]  Kazunori Otsuka,et al.  A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients , 2013, Cancer Chemotherapy and Pharmacology.

[86]  A. Al-Chalabi,et al.  The epidemiology of ALS: a conspiracy of genes, environment and time , 2013, Nature Reviews Neurology.

[87]  P. Lansdorp,et al.  Telomere length measurements in leukocyte subsets by automated multicolor flow‐FISH , 2003, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[88]  A. Shimatsu,et al.  Colloidal submicron-particle curcumin exhibits high absorption efficiency-a double-blind, 3-way crossover study. , 2015, Journal of nutritional science and vitaminology.

[89]  E. Fisher,et al.  SOD1 Function and Its Implications for Amyotrophic Lateral Sclerosis Pathology , 2015, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[90]  A. Akaike,et al.  Potential protective effect of highly bioavailable curcumin on an oxidative stress model induced by microinjection of sodium nitroprusside in mice brain. , 2014, Food & function.

[91]  V. Meininger,et al.  APOE: A potential marker of disease progression in ALS , 2002, Neurology.

[92]  Xun Hu,et al.  TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.

[93]  P. O’Reilly,et al.  Identification of seven loci affecting mean telomere length and their association with disease , 2013, Nature Genetics.

[94]  P. Thongnopnua,et al.  Effect of Different Curcuminoid Supplement Dosages on Total In Vivo Antioxidant Capacity and Cholesterol Levels of Healthy Human Subjects , 2011, Phytotherapy research : PTR.

[95]  R. Reddel,et al.  Telomere elongation in immortal human cells without detectable telomerase activity. , 1995, The EMBO journal.

[96]  Jing Zhao,et al.  Neuroprotection by Curcumin in Ischemic Brain Injury Involves the Akt/Nrf2 Pathway , 2013, PloS one.

[97]  Yansu Guo,et al.  Neuroprotection by Monocarbonyl Dimethoxycurcumin C: Ameliorating the Toxicity of Mutant TDP-43 via HO-1 , 2014, Molecular Neurobiology.

[98]  Carl D Langefeld,et al.  Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1 , 2013, Neurobiology of Aging.

[99]  Ole Gredal,et al.  Toxicity of Familial ALS-Linked SOD1 Mutants from Selective Recruitment to Spinal Mitochondria , 2004, Neuron.

[100]  J. Haines,et al.  Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia , 2011, Nature.

[101]  Ryan M. Layer,et al.  SpeedSeq: Ultra-fast personal genome analysis and interpretation , 2014, Nature Methods.

[102]  O. Hardiman,et al.  Heritability of Amyotrophic Lateral Sclerosis: Insights From Disparate Numbers. , 2015, JAMA neurology.

[103]  S. Petri,et al.  Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB–mediated pathogenic pathways , 2011, The Journal of experimental medicine.

[104]  J. Belsh ALS diagnostic criteria of El Escorial Revisited: do they meet the needs of clinicians as well as researchers? , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[105]  Xun Hu,et al.  Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.

[106]  W. Ling,et al.  Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice. , 2012, World journal of diabetes.

[107]  Yansu Guo,et al.  Mitochondrial dysfunction in human TDP-43 transfected NSC34 cell lines and the protective effect of dimethoxy curcumin , 2012, Brain Research Bulletin.

[108]  B. Gao,et al.  Clinical Pharmacology: Advances and Applications Dovepress the Clinical Potential of Influencing Nrf2 Signaling in Degenerative and Immunological Disorders , 2022 .

[109]  D. Brenner,et al.  Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. , 1999, Journal of immunology.

[110]  E. Blackburn,et al.  Impartial comparative analysis of measurement of leukocyte telomere length/DNA content by Southern blots and qPCR , 2011, Nucleic acids research.

[111]  G. Appendino,et al.  Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. , 2011, Journal of natural products.

[112]  P. Shaw,et al.  Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. , 2010, Free radical biology & medicine.

[113]  T. Gillingwater,et al.  A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. , 2004, American journal of human genetics.

[114]  R. Layzer,et al.  Subacute, reversible motor neuron disease , 1991, Neurology.

[115]  P. Popovich,et al.  Microglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis , 2014, Neuron.

[116]  Geoffrey Burnstock,et al.  Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice , 2004, Nature Medicine.

[117]  S. Srichairatanakool,et al.  Improvement in oxidative stress and antioxidant parameters in beta-thalassemia/Hb E patients treated with curcuminoids. , 2010, Clinical biochemistry.

[118]  B. Miller,et al.  Phytochemical Activation of Nrf2 Protects Human Coronary Artery Endothelial Cells against an Oxidative Challenge , 2012, Oxidative medicine and cellular longevity.

[119]  Heng Li Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.

[120]  Dirk Merkel,et al.  Docker: lightweight Linux containers for consistent development and deployment , 2014 .

[121]  A. Ludolph,et al.  Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.

[122]  K. Maeda,et al.  Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP , 2012, British journal of pharmacology.

[123]  S. Ajroud‐Driss,et al.  SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. , 2011, Archives of neurology.

[124]  J. Julien,et al.  Early-Stage Treatment with Withaferin A Reduces Levels of Misfolded Superoxide Dismutase 1 and Extends Lifespan in a Mouse Model of Amyotrophic Lateral Sclerosis , 2014, Neurotherapeutics.

[125]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[126]  S. Deep,et al.  Curcumin binds to the pre-fibrillar aggregates of Cu/Zn superoxide dismutase (SOD1) and alters its amyloidogenic pathway resulting in reduced cytotoxicity. , 2015, Biochimica et biophysica acta.

[127]  C. Sander,et al.  Determinants of protein function revealed by combinatorial entropy optimization , 2007, Genome Biology.

[128]  Richard Durbin,et al.  Estimating telomere length from whole genome sequence data , 2014, Nucleic acids research.

[129]  Pamela A McCombe,et al.  Effects of gender in amyotrophic lateral sclerosis. , 2010, Gender medicine.

[130]  E. Génin,et al.  A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. , 2014, Brain : a journal of neurology.

[131]  C. Azzalin,et al.  Telomere elongation chooses TERRA ALTernatives , 2015, RNA biology.

[132]  W. Xu,et al.  Curcumin attenuates urinary excretion of albumin in type II diabetic patients with enhancing nuclear factor erythroid-derived 2-like 2 (Nrf2) system and repressing inflammatory signaling efficacies. , 2015, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[133]  N. Pearce,et al.  Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study , 2014, The Lancet Neurology.